Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3

Together, Mounjaro and Zepbound brought in $11.98 billion in the third quarter even with price decreases for the medicines.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top